Evaluation of tumor vaccine generation in a phase II multicenter trial of single autologous hematopoietic cell transplant (autoHCT) followed by lenalidomide maintenance for multiple myeloma (MM) with or without vaccination with dendritic cell/myeloma fusions (DC/MM fusion vaccine): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1401 Meeting Abstract

  

Authors:	Avigan, D. E.; Shah, N.; Logan, B.; Zhu, J.; Bisharat, L.; Callander, N. S.; Chodon, T.; Dhakal, B.; Efebera, Y. A.; Geller, N.; Hematti, P.; Herman, M.; Lazarus, H. M.; McKenna, D. H. Jr; Nelson, C.; Nooka, A.; O'Brien, K.; O'Donnell, L. C.; Rapoport, A. P.; Rosenblatt, J.; Soifer, R. J.; Stroopinsky, D.; Torka, P.; Uhl, L.; Waller, E. K.; Wu, J.; Young, J. W.; Pasquini, M. C.; Chung, D. J.
Abstract Title:	Evaluation of tumor vaccine generation in a phase II multicenter trial of single autologous hematopoietic cell transplant (autoHCT) followed by lenalidomide maintenance for multiple myeloma (MM) with or without vaccination with dendritic cell/myeloma fusions (DC/MM fusion vaccine): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1401
Meeting Title:	Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	26
Issue:	3 Suppl.
Meeting Dates:	2020 Feb 19-23
Meeting Location:	Orlando, FL
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2020-03-01
Start Page:	S62
End Page:	S63
Language:	English
ACCESSION:	WOS:000516887900084
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2019.12.230
Notes:	Meeting Abstract: 83 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/164045